{"id":"NCT02442778","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","briefTitle":"Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Participants With Dementia of the Alzheimer's Type","officialTitle":"A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 (Deuterated [d6]-Dextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-11-11","primaryCompletion":"2019-08-14","completion":"2019-09-09","firstPosted":"2015-05-13","resultsPosted":"2022-09-09","lastUpdate":"2022-09-09"},"enrollment":522,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Agitation in Participants With Dementia of the Alzheimer's Type"],"interventions":[{"type":"DRUG","name":"AVP-786-18","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"AVP-786-28","otherNames":[]},{"type":"DRUG","name":"AVP-786-42.63","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"AVP-786-28","type":"EXPERIMENTAL"},{"label":"AVP-786-42.63","type":"EXPERIMENTAL"}],"summary":"Participants with agitation secondary to dementia of the Alzheimer's type. The diagnosis of probable Alzheimer's disease (AD) will be based on the \"2011 Diagnostic Guidelines for Alzheimer's Disease\" issued by the National Institute on Aging (NIA)-Alzheimer's Association (AA) workgroups.","primaryOutcome":{"measure":"Change From Baseline to Week 12 in the Cohen-Mansfield Agitation Inventory (CMAI) Composite Score","timeFrame":"Baseline, Week 12","effectByArm":[{"arm":"Placebo","deltaMin":73.7,"sd":21.13},{"arm":"AVP-786-28","deltaMin":68.8,"sd":19.39},{"arm":"AVP-786-42.63","deltaMin":71.3,"sd":20.87}],"pValues":[{"comp":"OG000 vs OG001","p":"0.789"},{"comp":"OG000 vs OG002","p":"0.200"}]},"eligibility":{"minAge":"50 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":3},"locations":{"siteCount":83,"countries":["United States","Canada"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":10,"n":210},"commonTop":["Fall","Diarrhoea","Urinary tract infection","Agitation","Somnolence"]}}